IWGT comet final2

Information about IWGT comet final2

Published on October 30, 2007

Author: Nivedi

Source: authorstream.com

Content

The Comet Assay Working Group:  The Comet Assay Working Group 4th International Workshop on Genotoxicity Testing San Francisco, CA September 10, 2005 Slide2:  Purpose: To enhance the ability of Comet assay test results to be used for regulatory decision making Primary Focus: The rodent alkaline (pH>13) Comet assay as a regulatory replacement/alternative for the in vivo unscheduled DNA Synthesis (UDS) assay Protocol Issues Validation Issues Establishing minimum reporting standards for Comet assay test results 4th IWGT Comet Assay Working Group Slide3:  In situations where evident toxicity is not present, can the limit dose only be tested in studies to evaluate the in vivo genotoxicity of a test substance? No! Downturns in response exist (bell-shaped dose-response curve) that are, for example, possibly due to altered bioavailability at higher dose levels Also, positive responses at multiple dose levels reinforce the biological relevance of the result. Rodent Alkaline (pH>13) Comet Assay: Multiple Dose Levels vs Limit Dose Slide4:  Does the method used to process tissues make a difference in the accuracy of the assay? Do we have enough data to decide? No! But we consider the issue unlikely to be a problem However, any international validation study would consider both processing methods for different tissues using reference chemicals with diverse mechanisms of action and covering a range of potencies Rodent Alkaline (pH>13) Comet Assay: Tissue Processing - Whole Cells vs Isolated Nuclei Rodent Alkaline (pH>13) Comet Assay: Do We Need to Include Measures of Cytotoxicity?:  Rodent Alkaline (pH>13) Comet Assay: Do We Need to Include Measures of Cytotoxicity? Possible methods include: Dye exclusion tests for membrane integrity (e.g., trypan blue) Dual dye tests for membrane integrity and metabolic competency Determining the frequency of comets that represent “dead“ cells Determining the frequency of cells with low molecular weight DNA Using histopathology in the event of positive findings Rodent Alkaline (pH>13) Comet Assay: Do We Need to Include Measures of Cytotoxicity?:  Rodent Alkaline (pH>13) Comet Assay: Do We Need to Include Measures of Cytotoxicity? Yes, measures of cytotoxicity need to be included! Studies should include histopathology to evaluate for necrosis and apoptosis when results are positive need to standardize ways to present histopathological findings The neutral diffusion assay can be used to identify the frequency of cells with low molecular weight DNA (i.e., dead cells) need to better define diffusion Can include membrane integrity dyes (e.g., trypan blue) if appropriate for the procedure used to isolate cells Slide7:  Image analysis (IA) or manual scoring IA is preferred but not required Scoring methodology (should all comets be scored?) Hedgehogs should be excluded from IA data collection; determining their frequency might be useful for data interpretation Which measure(s) of DNA migration can be used? For IA-based studies, tail moment, tail length, or % tail DNA can be used to evaluate for genotoxicity % tail DNA appears to be the most linearly related to dose and the easiest to compare across studies If tail moment is used, need to present tail length and % tail DNA data as well Data on the distribution of migration among cells should be presented Rodent Alkaline (pH>13) Comet Assay: Scoring - Measures of DNA Migration Slide8:  Need to develop and include historical negative/ positive control data The minimal number of studies needed is not defined but need enough studies to demonstrate stability of the extent of migration for negative/positive controls Criteria for determining the acceptability of new studies, based on historical control data, should be developed for each tissue by each lab The negative control should exhibit measurable DNA migration; a mean extent of migration corresponding to 10-20% tail DNA is useful if DNA crosslinking agents are to be detected, or the presence of crosslinks must be demonstrated using a second genotoxic agent Quality Control Issues Minimal Reporting Standards:  Minimal Reporting Standards To ensure that all studies can be independently evaluated, minimum reporting standards for regulatory submissions and publications will be developed that consistent with OECD in vivo genetic toxicology test method guidelines Comet Assay Validation (1):  Comet Assay Validation (1) Validation discussed briefly; the need is to: Establish an international “Management Team” Obtain funding, at least for chemical purchase and distribution Review current status of the rodent alkaline Comet assay (need to obtain raw data) Identify most appropriate protocol(s) Identify chemicals to test coded in order to compare Comet assay performance against UDS, MN, & carcinogenicity test results Identify participating labs (preferably GLP-compliant) Develop optimal statistical methods for evaluating validation data Comet Assay Validation (2):  Comet Assay Validation (2) Conduct phased/modular approach Phase 1 - generate historical negative/positive control data Phase 2 - test 3 coded substances to demonstrate cross lab performance (some labs may be excluded after this phase) Phase 3 - test x coded substances to demonstrate reproducibility within and across labs Phase 4 - test additional coded substances to demonstrate accuracy Data analyzed at each phase by the Management Team for lab performance and for assay relevance (accuracy) and reliability

Related presentations


Other presentations created by Nivedi

7 habits of highly effective ir
24. 10. 2007
0 views

7 habits of highly effective ir

Intro to Middle East
23. 10. 2007
0 views

Intro to Middle East

Ulysses
01. 10. 2007
0 views

Ulysses

chasm
02. 10. 2007
0 views

chasm

english version
03. 10. 2007
0 views

english version

griffin BGP tutorial
07. 10. 2007
0 views

griffin BGP tutorial

eurjap2004pres
09. 10. 2007
0 views

eurjap2004pres

aboriginal art
10. 10. 2007
0 views

aboriginal art

Galloway
15. 10. 2007
0 views

Galloway

room
15. 10. 2007
0 views

room

keymicrobial rosenberg
23. 10. 2007
0 views

keymicrobial rosenberg

franklin
15. 10. 2007
0 views

franklin

JavaVsDotNET
21. 10. 2007
0 views

JavaVsDotNET

strategies maximize
29. 10. 2007
0 views

strategies maximize

rehder050407
10. 12. 2007
0 views

rehder050407

Chuck Bedsole
25. 10. 2007
0 views

Chuck Bedsole

WA1 2 Redmond
29. 10. 2007
0 views

WA1 2 Redmond

2005 Hand Washing Findings rev
30. 10. 2007
0 views

2005 Hand Washing Findings rev

ch5slides
07. 11. 2007
0 views

ch5slides

Turkey CoalRestructuring
26. 11. 2007
0 views

Turkey CoalRestructuring

chapter 28
23. 12. 2007
0 views

chapter 28

Crisis Management Lecture 2
29. 12. 2007
0 views

Crisis Management Lecture 2

Lecture 25
16. 10. 2007
0 views

Lecture 25

DERMATOLOGY QUIZ ANSWERS
05. 01. 2008
0 views

DERMATOLOGY QUIZ ANSWERS

Maeve Foreman
07. 01. 2008
0 views

Maeve Foreman

revNotes1stMC
04. 10. 2007
0 views

revNotes1stMC

Schuster
11. 10. 2007
0 views

Schuster

mccay4
12. 10. 2007
0 views

mccay4

Presentazione ICE TUNISI
23. 10. 2007
0 views

Presentazione ICE TUNISI

Kapitel4
24. 10. 2007
0 views

Kapitel4

CAARI Lab 00
12. 10. 2007
0 views

CAARI Lab 00

Taipei August 05
19. 10. 2007
0 views

Taipei August 05

LOWBACKPAIN2
16. 02. 2008
0 views

LOWBACKPAIN2

2004L9Stat246
24. 02. 2008
0 views

2004L9Stat246

berne
28. 02. 2008
0 views

berne

PAM
23. 10. 2007
0 views

PAM

slides bird flu
30. 03. 2008
0 views

slides bird flu

A105 003 Sky
13. 11. 2007
0 views

A105 003 Sky

hunter lovins ifm07
30. 10. 2007
0 views

hunter lovins ifm07

Psicotrópicos
24. 10. 2007
0 views

Psicotrópicos

IntroToRealOptions
16. 04. 2008
0 views

IntroToRealOptions

QUMRAN COMPRESSED
14. 02. 2008
0 views

QUMRAN COMPRESSED

third exam review
18. 04. 2008
0 views

third exam review

McGraw Hill
22. 04. 2008
0 views

McGraw Hill

posp72 0
11. 10. 2007
0 views

posp72 0

7 Metlin
11. 10. 2007
0 views

7 Metlin

cshcn
07. 05. 2008
0 views

cshcn

ls3 d2 room22
30. 04. 2008
0 views

ls3 d2 room22

Open GL
02. 05. 2008
0 views

Open GL

physics of accelerators
02. 05. 2008
0 views

physics of accelerators

thuy
02. 05. 2008
0 views

thuy

maryland 080202
19. 02. 2008
0 views

maryland 080202

CONFECA2005
22. 10. 2007
0 views

CONFECA2005

20061201 afrinic5 report
27. 03. 2008
0 views

20061201 afrinic5 report

Roe Summer Lecture
13. 10. 2007
0 views

Roe Summer Lecture

opa
22. 10. 2007
0 views

opa

break this glass update
07. 01. 2008
0 views

break this glass update

GGunn Feb05
12. 03. 2008
0 views

GGunn Feb05

cronqvist
31. 12. 2007
0 views

cronqvist

jcdl
02. 10. 2007
0 views

jcdl

jje
10. 10. 2007
0 views

jje

milcho
15. 10. 2007
0 views

milcho

Masahiro Satake session 6
09. 10. 2007
0 views

Masahiro Satake session 6

TIANS 2003 final
11. 03. 2008
0 views

TIANS 2003 final

mariana
22. 10. 2007
0 views

mariana

Schulthess X1Review Feb2004
15. 10. 2007
0 views

Schulthess X1Review Feb2004

april croatia
26. 03. 2008
0 views

april croatia

200793142735
03. 01. 2008
0 views

200793142735

CultureClashWestPoint
17. 10. 2007
0 views

CultureClashWestPoint

notifications
10. 10. 2007
0 views

notifications

Daar
16. 10. 2007
0 views

Daar

IGEM2006 Imperial Powerpoint
01. 01. 2008
0 views

IGEM2006 Imperial Powerpoint

booklet osijek2006
18. 03. 2008
0 views

booklet osijek2006

12km MM5 Issues Mar8 9 2005
29. 10. 2007
0 views

12km MM5 Issues Mar8 9 2005